Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **intestinal epithelial barrier** refers to the complex structure formed primarily by a single layer of specialized epithelial cells lining the gut. This layer acts as both a physical and functional interface between the external environment within the gut lumen and the internal tissues of the body. The main components include absorptive enterocytes; mucus-secreting goblet cells; hormone-producing enteroendocrine cells; antimicrobial peptide-secreting Paneth cells; tuft cells involved in immune signaling; tight junctions connecting adjacent epithelial cells; an overlying mucus layer produced mainly by goblet cells; underlying immune cell populations in the lamina propria; and interactions with commensal microbiota. This **barrier** serves several essential functions: • It limits passage of harmful microorganisms and antigens while allowing absorption of nutrients. • It regulates paracellular transport through tight junction proteins. • It participates actively in innate immunity via pattern recognition receptors that sense microbial products. • Its dysfunction—manifested as increased intestinal permeability—is implicated in various diseases including IBD, IBS, celiac disease, colorectal cancer, metabolic disorders such as diabetes and obesity. Restoration or maintenance of **epithelial barrier integrity** is considered an important therapeutic goal in gastrointestinal diseases characterized by chronic inflammation or impaired mucosal defense. However—as currently defined—it is not itself a discrete druggable target like an enzyme or receptor but rather describes an emergent property resulting from coordinated activity among many cellular components.[1][2][3][4][5]
Therapies may act by reducing inflammation or promoting mucosal healing but do not directly target "barrier integrity" as a molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial barrier integrity.